Search

Hajime Kamiya, Mehmet Ceyhan, Konstantin Mironov, Gabriela Echániz-Aviles, Jay Lucidarme, Susan Meiring, Yanet Climent, Muhamed-Kheir Taha, Philippe De Wals, Bianca Stenmark, Dominique A. Caugant, Xilian Bai, Marco Aurélio Palazzi Sáfadi, Josefina Carlos, Caroline Trotter, Ener Cagri Dinleyici, Vinny Smith, Reinaldo Acevedo, Bingqing Zhu, Hannah Christensen, Zhujun Shao, Ray Borrow, Andromachi Karachaliou, Julio A. Vázquez, Ahmed Hakawi, Robert Steffen, Finlay Institute of Vaccines, Public Health England [London], Norwegian Institute of Public Health [Oslo] (NIPH), University of the East – Ramon Magsaysay Memorial Medical Center [Philippines], Faculty of Medicine [Hacettepe University], Hacettepe University = Hacettepe Üniversitesi, University of Bristol [Bristol], Université Laval [Québec] (ULaval), Eskisehir Osmangazi University, National Institute of Public Health = Instituto Nacional de Salud Pública [Cuernavaca, Mexique] (INSP), Ministry of Health [Riyadh], National Institute of Infectious Diseases [Tokyo], University of Cambridge [UK] (CAM), National Institute for Communicable Diseases [Johannesburg] (NICD), Central Research Institute of Epidemiology [Moscow], FCM Santa Casa de São Paulo School of Medical Sciences [São Paulo], Chinese Centre for Disease Control and Prevention, Meningitis Research Foundation [Bristol], Universität Zürich [Zürich] = University of Zurich (UZH), Örebro University Hospital [Örebro, Sweden], Centre National de Référence des Méningocoques et Haemophilus influenzae - National Reference Center Meningococci and Haemophilus influenzae (CNR), Institut Pasteur [Paris], Institute of Health Carlos III, R. Borrow, J. Lucidarme and X. Bai perform contract work for Public Health England on behalf of GSK, PATH, Sanofi Pasteur and Pfizer. M.K. Taha performs contract work for the Institut Pasteur funded by GSK, Pfizer and Sanofi Pasteur. S. Meiring has received grant funding for a meningococcal carriage study by Sanofi Pasteur. G. Enchaniz-Aviles has received support for research projects from GSK and Pfizer. J.A. Vázquez performs contract work for the Institute of Health Carlos III funded by GSK and Pfizer. P. De Wals has received research grants, and reimbursements of travel expenses from vaccine manufacturers including GSK, Novartis, Sanofi Pasteur, and Pfizer, as well as from governmental agencies including the Quebec Ministry of Health and Social Services, Health Canada, and the Public Health Agency of Canada. M.A.P. Sáfadi has received grants to support research projects and consultancy fees from GSK, Pfizer and Sanofi Pasteur. C. Trotter has received consulting fees from GSK and an honorarium from Sanofi-Pasteur for developing and delivering a modeling workshop at a previous GMI meeting. H. Christensen has received reimbursements of travel expenses and, for previous GMI meetings, honoraria, from Sanofi-Pasteur, consultancy fees from IMS Health and AstraZeneca all paid to her employer. She is supported by the NIHR Health Protection Research Unit in Evaluation of Interventions at the University of Bristol. The views expressed in this article are those of the author(s) and not necessarily those of the NHS, the NIHR, or the Department of Health and Social Care., Institut Pasteur [Paris] (IP), and Sanofi Pasteur

Hannah Christensen, Caroline Trotter, Hajime Kamiya, Sergey Sidorenko, Josefina Carlos, Dominique A. Caugant, Roberto Debbag, Ray Borrow, Marco Aurélio Palazzi Sáfadi, Muhamed-Kheir Taha, Chris Head, Philippe De Wals, Jamie Findlow, Daphne Holt, Anne von Gottberg, Gabriela Echániz-Aviles, Pedro Alarcón, Samir K. Saha, Julio A. Vázquez Moreno, Manchester Royal Infirmary, University of Manchester [Manchester], Instituto de Salud Pública de Chile (ISP), University of the East – Ramon Magsaysay Memorial Medical Center [Philippines], Norwegian Institute of Public Health [Oslo] (NIPH), University of the West of England [Bristol] (UWE Bristol), Malvinas Children's Hospital [Buenos Aires], Université Laval [Québec] (ULaval), National Institute of Public Health = Instituto Nacional de Salud Pública [Cuernavaca, Mexique] (INSP), Meningitis Research Foundation [Bristol], Confederation of Meningitis Organisations [Bristol] (CoMO), National Institute of Infectious Diseases [Tokyo], Dhaka Shishu Hospital [Bangladesh], Scientific Research Institute of Children's Infections [Saint-Petersburg, Russia], Centre National de Référence des Méningocoques et Haemophilus influenzae - National Reference Center Meningococci and Haemophilus influenzae (CNR), Institut Pasteur [Paris], University of Cambridge [UK] (CAM), Institute of Health Carlos III, National Institute for Communicable Diseases [Johannesburg] (NICD), FCM Santa Casa de São Paulo School of Medical Sciences [São Paulo], The GMI is funded by an educational grant from Sanofi Pasteur, however, the group is not led in any way by the company. GMI members determine meeting agenda items and lead the discussions and outputs. Medical writing support was provided by Shelley Lindley, PhD, of PAREXEL, which was funded by Sanofi Pasteur. R Borrow and J Findlow perform contract research on behalf of Public Health England for Baxter Biosciences, GlaxoSmithKline, Novartis, Pfizer, Sanofi Pasteur, and Sanofi Pasteur MSD. DA Caugant has performed in the past contract research on behalf of the Norwegian Institute of Public Health for Novartis, Pfizer, and Sanofi Pasteur. H Christensen has received an honorarium from Sanofi Pasteur for running a GMI modeling workshop paid to her employer. Furthermore, H Christensen is supported by the National Institute for Health Research [PDF-2012-05-245] and is a member of the National Institute for Health Research Health Protection Research Unit (NIHR HPRU) in Evaluation of Interventions at the University of Bristol, UK. S Sidorenko has received grants from Pfizer, outside the submitted work. P De Wals has received research grants and reimbursements of travel expenses from vaccine manufacturers including GlaxoSmithKline, Novartis, Sanofi Pasteur, and Pfizer, as well as from governmental agencies including the Quebec Ministry of Health and Social Services, Health Canada, and the Public Health Agency of Canada. J Carlos has received research grant support from GlaxoSmithKline, Novartis, and Sanofi Pasteur, however, no conflict of interest relevant to this manuscript is reported. M-K Taha performs contract research on behalf of Institut Pasteur for GlaxoSmithKline, Novartis, Pfizer, and Sanofi Pasteur. C Trotter received a consulting payment from GlaxoSmithKline in 2013 for critical review of a health economic model of meningococcal vaccines and an honorarium from Sanofi Pasteur in 2015 for running a GMI modeling workshop. JA Vázquez Moreno performed contract research on behalf of Institute of Health Carlos III for Baxter Biosciences, GlaxoSmithKline, Novartis, Pfizer, and Sanofi Pasteur. A von Gottberg received research funding from Pfizer. MAP Sáfadi has received grants to support research projects from GlaxoSmithKline, Novartis, Pfizer, and Sanofi Pasteur. This work is produced by the authors under the terms of the research training fellowships issued by the NIHR. The views expressed in this publication are those of the authors and not necessarily those of the National Health Service, NIHR, the Department of Health, or Public Health England. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed., Global Meningococcal Initiative, and Institut Pasteur [Paris] (IP)